Melatonin and circadian biology in human cardiovascular disease

Journal of Pineal Research

Volumn 49, Issue 1, 2010, Pages 14-22

  Dominguez Rodriguez, Alberto ^a   Abreu Gonzalez, Pedro ^b   Sanchez Sanchez, Juan J ^c   Kaski, Juan C ^d   Reiter, Russel J ^e  

^a HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

^b UNIVERSIDAD DE LA LAGUNA   (Spain)

^c Biology Section Apdo 863 E 41080   (Spain)

^d ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^e UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

cardiovascular disease; cardiovascular system; circadian rhythm; heart; melatonin

Indexed keywords

BIOLOGICAL MARKER; MELATONIN; NEUROHORMONE;

BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; CHRONOBIOLOGY; CIRCADIAN RHYTHM; ENVIRONMENTAL FACTOR; EPIGENETICS; GENE EXPRESSION; HEART RATE; HUMAN; LIGHT DARK CYCLE; MOLECULAR CLOCK; REGULATORY MECHANISM; REVIEW; RISK BENEFIT ANALYSIS; STIMULUS RESPONSE; SUPRACHIASMATIC NUCLEUS; PATHOPHYSIOLOGY; PHYSIOLOGY;

CARDIOVASCULAR DISEASES; CIRCADIAN RHYTHM; HUMANS; MELATONIN;

EID: 77954336406     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/j.1600-079X.2010.00773.x     Document Type: Review

References (136)

1. Muller JE, Tofler GH. Circadian variation and cardiovascular disease. N Engl J Med 1991 325 : 1038 1039.
2. Willich SN, Goldberg RJ, Maclure M et al. Increased onset of sudden cardiac death in the first three hours after awakening. Am J Cardiol 1992 70 : 65 68.
3. Rajaratnam SM, Arendt J. Health in a 24-h society. Lancet 2001 358 : 999 1005.
4. Knutsson A. Health disorders of shift workers. Occup Med (Lond) 2003 53 : 103 108.
5. Young ME, Bray MS. Potential role for peripheral circadian clock dyssynchrony in the pathogenesis of cardiovascular dysfunction. Sleep Med 2007 8 : 656 667.
6. Young ME. The circadian clock within the heart: potential influence on myocardial gene expression, metabolism, and function. Am J Physiol Heart Circ Physiol 2006 290 : H1 H16.
7. Durgan DJ, Hotze MA, Tomlin TM et al. The intrinsic circadian clock within the cardiomyocyte. Am J Physiol Heart Circ Physiol 2005 289 : H1530 H1541.
8. Damiola F, Le Minh N, Preitner N et al. Restricted feeding uncouples circadian oscillators in peripheral tissues from the central pacemaker in the suprachiasmatic nucleus. Genes Dev 2000 14 : 2950 2961.
9. Sewerynek E. Metabolism and the cardiovascular system. Neuro Endocrinol Lett 2002 23 : 79 83.
10. Muller JE. Circadian variation in cardiovascular events. Am J Hypertens 1999 12 : 35S 42S.
11. Marsh EE, Biller J, Adams HP et al. Circadian variation in onset of acute ischemic stroke. Arch Neurol 1990 47 : 1178 1180. (Pubitemid 20380995)
12. Gupta A, Shetty H. Circadian variations in stroke-a prospective-hospital- based study. Int J Clin Pract 2005 59 : 1272 1275.
13. Degaute JP, Van Cauter E, Van De Borne P, Linkowski P. Twenty-four-hour blood pressure and heart rate profiles in humans. A twin study. Hypertension 1994 23 : 244 253.
14. Oishi K, Kasamatsu M, Ishida N. Gene- and tissue-specific alterations of circadian clock gene expression in streptozotocin-induced diabetic mice under restricted feeding. Biochem Biophys Res Commun 2004 317 : 330 334.
15. Young ME, Wilson CR, Razeghi P, Guthrie PH, Taegtmeyer H. Alterations of the circadian clock in the heart by streptozotocin-induced diabetes. J Mol Cell Cardiol 2002 34 : 223 231.
16. Harma MI, Ilmarinen JE. Towards the 24-hour society-New approaches for aging shift workers?. Scand J Work Environ Health 1999 25 : 610 615.
17. Knutsson A, Akerstedt T, Jonsson BG, Orth-Gomer K. Increased risk of ischaemic heart disease in shift workers. Lancet 1986 12 : 89 92.
18. Koller M. Health risks related to shift work. An example of time-contingent effects of long-term stress. Int Arch Occup Environ Health 1983 53 : 59 75.
19. Hausmann D, Lichtlen PR, Nikutta P, Wenzlaff P et al. Circadian variation of myocardial ischemia in patients with stable coronary artery disease. Chronobiol Int 1991 8 : 385 398.
20. Ridker PM, Manson JE, Buring JE et al. Circadian variation of acute myocardial infarction and the effect of low-dose aspirin in a randomized trial of physicians. Circulation 1990 82 : 897 902.
21. Muller JE, Tofler GH, Willich SN, Stone PH. Circadian variation of cardiovascular disease and sympathetic activity. J Cardiovasc Pharmacol 1987 10 (Suppl 2 S104 S109.
22. Manfredini R, Gallerani M, Portaluppi F, Salmi R et al. Chronobiological patterns of onset of acute cerebrovascular diseases. Thromb Res 1997 88 : 451 463.
23. Gallerani M, Manfredini R, Ricci L et al. Chronobiological aspects of acute cerebrovascular diseases. Acta Neurol Scand 1993 87 : 482 487.
24. Muller JE, Stone PH, Turi ZG et al. Circadian variation in the frequency on onset of acute myocardial infarction. N Engl J Med 1985 313 : 1315 1322.
25. Couch RD. Travel, time zones, and sudden cardiac death. Emporiatric pathology. Am J Forensic Med Pathol 1990 11 : 106 111.
26. Krantz DS, Kop WJ, Gabbay FH et al. Circadian variation of ambulatory myocardial ischemia. Triggering by daily activities and evidence for an endogenous circadian component. Circulation 1996 93 : 1364 1371.
27. Hu K, Ivanov P, Hilton MF et al. Endogenous circadian rhythm in an index of cardiac vulnerability independent of changes in behavior. Proc Natl Acad Sci USA 2004 101 : 18223 18227.
28. Manfredini R, Boari B, Smolensky MH et al. Circadian variation in stroke onset: identical temporal pattern in ischemic and hemorrhagic events. Chronobiol Int 2005 22 : 417 453.
29. Kuniyoshi FH, Garcia-Touchard A, Gami AS et al. Day-night variation of acute myocardial infarction in obstructive sep apnea. J Am Coll Cardiol 2008 52 : 343 346.
30. Reilly D, Westgate EJ, Fitzgerald GA. Peripheral circadian clocks in the vasculature. Arterioscler Thromb Vasc Biol 2007 27 : 1697 1705.
31. Scheer FA, Evoniuk H, Kelly E et al. Effect of circadian system and behavioral stressors on platelet activity and reactivity: implications for the morning peak in cardiovascular incidents. Sleep 2009 32 : A7.
32. Brezinski DA, Tofler GH, Muller JE et al. Association with assumption of the upright posture. Circulation 1988 78 : 35 40.
33. Young ME, Razeghi P, Taegtmeyer H. Clock genes in the heart: characterization and attenuation with hypertrophy. Circ Res 2001 88 : 1142 1150.
34. Rudic RD, Mcnamara P, Reilly D et al. Bioinformatic analysis of circadian gene oscillation in mouse aorta. Circulation 2005 112 : 2716 2724.
35. Curtis AM, Cheng Y, Kapoor S et al. Circadian variation of blood pressure and the vascular response to asynchronous stress. Proc Natl Acad Sci USA 2007 104 : 3450 3455.
36. Viswambharan H, Carvas JM, Antic V et al. Mutation of the circadian clock gene Per2 alters vascular endothelial function. Circulation 2007 115 : 2188 2195.
37. Weksler BB, Marcus AJ, Jaffe EA. Synthesis of prostaglandin I2 (prostacyclin) by cultured human and bovine endothelial cells. Proc Natl Acad Sci USA 1997 74 : 3922 3926.
38. Vanhoutte PM. Say NO to ET. J Auton Nerv Syst 2000 81 : 271 277.
39. Luscher TF, Richard V, Tschudi M et al. Endothelial control of vascular tone in large and small coronary arteries. J Am Coll Cardiol 1990 15 : 519 527.
40. Rees DD, Palmer RM, Moncada S. Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci USA 1989 86 : 3375 3378.
41. Elherik K, Khan F, Mclaren M et al. Circadian variation in vascular tone and endothelial cell function in normal males. Clin Sci (Lond) 2002 102 : 547 552.
42. Otto ME, Svatikova A, Barretto RB et al. Early morning attenuation of endothelial function in healthy humans. Circulation 2004 109 : 2507 2510.
43. Bridges AB, Mclaren M, Saniabadi A et al. Circadian variation of endothelial cell function, red blood cell deformability and dehydro-thromboxane B2 in healthy volunteers. Blood Coagul Fibrinolysis 1991 2 : 447 452.
44. Muller JE. Circadian variation and triggering of acute coronary events. Am Heart J 1999 137 : S1 S8.
45. Pinotti M, Bertolucci C, Portaluppi F et al. Daily and circadian rhythms of tissue factor pathway inhibitor and factor VII activity. Arterioscler Thromb Vasc Biol 2005 25 : 646 649.
46. Kanabrocki EL, George M, Hermida RC et al. Day-night variations in blood levels of nitric oxide, T-TFPI, and E-selectin. Clin Appl Thromb Hemost 2001 7 : 339 345.
47. Soulban G, Labrecque G. Circadian rhythms of blood clotting time an coagulation factors II, VII, IX and X in rats. Life Sci 1989 45 : 2485 2489.
48. Brenner WF, Sothern RB, Kanabrocki EL et al. Relation between circadian patterns in levels of circulating lipoprotein(a), fibrinogen, platelets, and related lipid variables in men. Am Heart J 2000 139 : 164 173.
49. Erren TC, Reiter RJ. Defining chronodisruption. J Pineal Res 2009 46 : 245 247.
50. Cabezas-Cerrato J, Hermida RC, Cabezas-Agricola JM, Ayala DE. Cardiac autonomic neuropathy, estimated cardio-vascular risk, and circadian blood pressure pattern in diabetes mellitus. Chronobiol Int 2009 26 : 942 957.
51. Dominguez-Rodriguez A, Abreu-Gonzalez P, Kaski JC. Disruption of normal circadian rhythms and cardiovascular events. Heart Metab 2009 44 : 11 15.
52. Dominguez-Rodriguez A, Samimi-Fard S, Abreu-Gonzalez P, Kaski JC. Melatonina y atherosclerosis coronaria. Clin Invest Arterioscl 2009 21 : 247 256.
53. Reiter RJ. Pineal melatonin: cell biology of its synthesis and its physiological interactions. Endocr Rev 1991 12 : 151 180.
54. Reiter RJ. The melatonin rhythm: both a clock and a calendar. Experientia 1993 49 : 654 664.
55. Reiter RJ, Richardson BA, Johnson LY. Pineal melatonin rhythm: reduction in aging Syrian hamsters. Science 1980 210 : 1372 1373.
56. Reiter RJ, Craft CM, Johnson JEJR et al. Age-associated reduction in nocturnal pineal melatonin levels in female rats. Endocrinology 1981 109 : 1295 1297.
57. Sack RL, Lewy AJ, Erb DL et al. Human melatonin production decreases with age. J Pineal Res 1986 3 : 379 388.
58. Sakotnik A, Liebmann PM, Stoschitzky K et al. Decreased melatonin synthesis in patients with coronary artery disease. Eur Heart J 1999 20 : 1314 1317.
59. Altun A, Yaprak M, Aktoz M et al. Impaired nocturnal synthesis of melatonin in patients with cardiac syndrome X. Neurosci Lett 2002 327 : 143 145.
60. Dominguez-Rodriguez A, Abreu-Gonzalez P, Garcia MJ et al. Decreased nocturnal melatonin levels during acute myocardial infarction. J Pineal Res 2002 33 : 248 252.
61. Yaprak M, Altun A, Vardar A et al. Decreased nocturnal synthesis of melatonin in patients with coronary artery disease. Int J Cardiol 2003 89 : 103 107.
62. Tengattini S, Reiter RJ, Tan DX et al. Cardiovascular diseases: protective effects of melatonin. J Pineal Res 2008 44 : 16 25.
63. Stoschitzky K, Sakotnik A, Lercher P et al. Influence of beta-blockers on melatonin release. Eur J Clin Pharmacol 1999 55 : 111 115.
64. Nathan PJ, Maguire KP, Burrows GD, Norman TR. The effect of atenolol, a β1-adrenergic antagonist, on nocturnal plasma melatonin secretion: evidence for a dose-response relationship in humans. J Pineal Res 1997 23 : 131 135.
65. Girotti L, Lago M, Ianavsky O et al. Low urinary 6-sulphatoxymelatonin levels in patients with coronary artery disease. J Pineal Res 2000 29 : 138 142.
66. Zawilska JB, Skene DJ, Arendt J. Physiology and pharmacology of melatonin in relation to biological rhythms. Pharmacol Rep 2009 61 : 383 410.
67. Hoebert M, Van Der Heijden KB, Van Geijlswijk IM, Smits MG. Long-term follow-up of melatonin treatment in children with ADHD and chronic sleep onset insomnia. J Pineal Res 2009 47 : 1 7.
68. Landmesser U, Harrison DG. Oxidant stress as marker for cardiovascular events: Ox marks the spot. Circulation 2001 104 : 2638 2640.
69. Muller-Wieland D, Behnke B, Koopmann K, Krone W. Melatonin inhibits LDL receptor activity and cholesterol synthesis in freshly isolated human mononuclear leukocytes. Biochem Biophys Res Commun 1994 203 : 416 421.
70. Kelly MR, Loo G. Melatonin inhibits oxidative modification of human low-density lipoprotein. J Pineal Res 1997 22 : 203 209.
71. Seegar H, Mueck AO, Lippert TH. Effect of melatonin and metabolites on cooper-mediated oxidation of low density lipoprotein. Br J Clin Pharmacol 1997 44 : 283 284.
72. Hoyos M, Guerrero JM, Perez-Cano R et al. Serum cholesterol and lipid peroxidation are decreased by melatonin in diet-induced hypercholesterolemic rats. J Pineal Res 2000 28 : 150 155.
73. Abuja PM, Liebman P, Hayn M et al. Antioxidant role of melatonin in lipid peroxidation of human LDL. FEBS Lett 1997 413 : 289 293.
74. Wakatsuki A, Okatani Y, Ikenoue N et al. Melatonin protects against oxidized low-density lipoprotein-induced inhibition of nitric oxide production in human umbilical artery. J Pineal Res 2001 31 : 281 288.
75. Dominguez-Rodriguez A, Abreu-Gonzalez P, Garcia-Gonzalez M et al. Elevated levels of oxidized low-density lipoprotein and impaired nocturnal synthesis of melatonin in patients with myocardial infarction. Atherosclerosis 2005 180 : 101 105.
76. Tamura H, Nakamura Y, Narimatsu A et al. Melatonin treatment in peri- and postmenopausal women elevates serum high-density lipoprotein cholesterol levels without influencing total cholesterol levels. J Pineal Res 2008 45 : 101 105.
77. Reiter RJ. Melatonin: lowering the high price of free radicals. News Physiol Sci 2000 15 : 246 250.
78. Chuang JI, Chen SS, Lin MT. Melatonin decreases brain serotonin release, arterial pressure and heart rate in rats. Pharmacology 1993 47 : 91 97.
79. Holmes SW, Sugden D. The effect of melatonin on pinealectomy-induced hypertension in the rat. Br J Pharmacol 1976 56 : 360 361.
80. Kawashima K, Miwa Y, Fujimoto K et al. Antihypertensive action of melatonin in the spontaneously hypertensive rat. Clin Exp Hypertens A 1987 9 : 1121 1131.
81. Karppanen H, Airaksinen MM, Sarkimaki I. Effects in rats of pinealectomy and oxypertine on spontaneous locomotor activity and blood pressure during various light schedules. Ann Med Exp Biol Fenn 1973 51 : 93 103.
82. Cagnacci A, Sodani R, Yen SSC. Melatonin enhances cortisol levels in aged women: reversible by estrogens. J Pineal Res 1997 22 : 81 85.
83. Cagnacci A, Arangino S, Angiolucci M et al. Influence of melatonin administration on the circulation of women. Am J Physiol 1998 274 : R335 R338.
84. Arangino S, Cagnacci A, Angiolucci M et al. Effects of melatonin on vascular reactivity, catecholamine levels, and blood pressure in healthy men. Am J Cardiol 1999 83 : 1417 1419.
85. Birau N, Peterssen U, Meyer C, Gottschalk J. Hypotensive effect of melatonin in essential hypertension. IRCS Med Sci 1981 9 : 906 911.
86. Reiter RJ, Tan DX, Korkmaz A. The circadian melatonin rhythm and its modulation: possible impact on hypertension. J Hypertens 2009 6 : S17 S20.
87. Reiter RJ, Tan DX. Melatonin and cardiac pathophysiology. Heart Metab 2009 44 : 31 34.
88. Pechanova O, Zicha J, Paulis L et al. The effect of N-acetylcysteine and melatonin in adult spontaneously hypertensive rats with established hypertension. Eur J Pharmacol 2007 561 : 129 136.
89. Erşahin M, Sehirli O, Toklu HZ et al. Melatonin improves cardiovascular function and ameliorates renal, cardiac and cerebral damage in rats with renovascular hypertension. J Pineal Res 2009 47 : 97 106.
90. Dominguez-Rodriguez A, Abreu-Gonzalez P, Kaski JC. Inflammatory systemic biomarkers in setting acute coronary syndromes- effects of the diurnal variation. Curr Drug Targets 2009 10 : 1001 1008.
91. Carrillo-Vico A, Guerrero JM, Lardone PJ, Reiter RJ. A review of the multiple actions of melatonin on the immune system. Endocrine 2005 27 : 189 200.
92. Veneroso C, Tuñón MJ, González-Gallego J, Collado PS. Melatonin reduces cardiac inflammatory injury induced by acute exercise. J Pineal Res 2009 47 : 184 191.
93. Dominguez-Rodriguez A, Abreu-Gonzalez P, Garcia M et al. Light/dark patterns of interleukin-6 in relation to the pineal hormone melatonin in patients with acute myocardial infarction. Cytokine 2004 26 : 89 93.
94. Dominguez-Rodriguez A, Garcia-Gonzalez M, Abreu-Gonzalez P et al. Relation of nocturnal melatonin levels to C-reactive protein concentration in patients with ST-segment elevation myocardial infarction. Am J Cardiol 2006 97 : 10 12.
95. Dominguez-Rodriguez A, Abreu-Gonzalez P, Garcia-Gonzalez MJ, Reiter RJ. Relation of nocturnal melatonin levels to serum matrix metalloproteinase-9 concentrations in patients with myocardial infarction. Thromb Res 2007 120 : 361 366.
96. Dominguez-Rodriguez A, Abreu-Gonzalez P, Garcia-Gonzalez MJ et al. Light/dark patterns of soluble vascular cell adhesion molecule-1 in relation to melatonin in patients with ST-segment elevation myocardial infarction. J Pineal Res 2008 44 : 65 69.
97. Reiter RJ, Tan DX, Leon J et al. When melatonin gets on your nerves: its beneficial actions in experimental models of stroke. Exp Biol Med 2005 230 : 104 117.
98. Cervantes M, Moralí G, Letechipía-Vallejo G. Melatonin and ischemia-reperfusion injury of the brain. J Pineal Res 2008 45 : 1 7.
99. Chen Z, Chua CC, Gao J et al. Prevention of ischemia/reperfusion-induced cardiac apoptosis and injury by melatonin is independent of glutathione peroxidase 1. J Pineal Res 2009 46 : 235 241.
100. Salie R, Harper I, Cillie C et al. Melatonin protects against ischaemic-reperfusion myocardial damage. J Mol Cell Cardiol 2001 33 : 343 357.
101. Tan DX, Manchester LC, Reiter RJ et al. Ischemia/reperfusion-induced arrhythmias in the isolated rat heart: prevention by melatonin. J Pineal Res 1998 25 : 184 191.
102. Szarszoi O, Asemu G, Vanecek J et al. Effects of melatonin on ischemia and reperfusion injury of the rat Herat. Cardiovasc Drugs Ther 2001 15 : 251 257.
103. Sahna E, Olmez E, Acet A. Effects of physiological and pharmacological concentrations of melatonin on ischemia-reperfusion arrhythmias in rats: can be the incidence of sudden cardiac death be reduced? J Pineal Res 2002 32 : 194 198.
104. Lee YM, Chen HR, Hsiao G et al. Protective effects of melatonin on myocardial ischemia/reperfusion injury in vivo. J Pineal Res 2002 33 : 72 80.
105. Rodriguez C, Mayo JC, Sainz RM et al. Regulation of antioxidant enzymes: a significant role for melatonin. J Pineal Res 2004 36 : 1 9.
106. Sahna E, Parlakpinar H, Turkoz Y, Acet A. Protective effects of melatonin on myocardial ischemia/reperfusion induced infarct size and oxidative damage. Physiol Res 2005 54 : 491 495.
107. Chen Z, Chua CC, Gao J et al. Protective effect of melatonin on myocardial infarction. Am J Physiol 2003 284 : H1618 H1624.
108. Dominguez-Rodriguez A, Abreu-Gonzalez P, Garcia-Gonzalez MJ et al. Association of ischemia-modified albumin and melatonin in patients with ST-elevation myocardial infarction. Atherosclerosis 2007 199 : 73 78.
109. Martino TA, Sole MJ. Molecular time: an often overlooked dimension to cardiovascular disease. Circ Res 2009 105 : 1047 1061.
110. Rüger M, Scheer FA. Effects of circadian disruption on the cardiometabolic system. Rev Endocr Metab Disord 2009, doi:.
111. Panda S, Antoch MP, Miller BH et al. Coordinated transcription of key pathways in the mouse by the circadian clock. Cell 2002 109 : 307 320.
112. Tucker T, Marra M, Friedman JM. Massively parallel sequencing: the next big thing in genetic medicine. Am J Hum Genet 2009 85 : 142 154.
113. Ragoussis J. Genotyping technologies for genetic research. Annu Rev Genomics Hum Genet 2009 10 : 117 133.
114. Blomeke B, Golka K, Griefahn B, Roemer HC. Arylalkylamine-N- acetyltransferase (AANAT) genotype as a personal trait in melatonin synthesis. J Toxicol Environ Health 2008 71 : 874 876.
115. Hohjoh H, Takasu M, Shishikura K et al. Significant association of the arylalkylamine N-acetyltransferase (AA-NAT) gene with delayed sleep phase syndrome. Neurogenetics 2003 4 : 151 153.
116. Wang H, Wu Z, Zhuang Q et al. Association study of tryptophan hydroxylase 1 and arylalkylamine N-acetyltransferase polymorphisms with adolescent idiopathic scoliosis in Han Chinese. Spine 2008 33 : 2199 2203.
117. Doi M, Takahashi Y, Komatsu R et al. Salt-sensitive hypertension in circadian clock-deficient Cry-null mice involves dysregulated adrenal Hsd3b6. Nat Med 2009, doi:.
118. Sturner WQ, Lynch HJ, Deng MH et al. Melatonin concentrations in the sudden infant death syndrome. Forensic Sci Int 1990 45 : 171 180.
119. Weissbluth L, Weissbluth M. Sudden infant death syndrome: a genetically determined impaired maturation of the photoneuroendocrine system. A unifying hypothesis. J Theor Biol 1994 167 : 13 25.
120. Dubocovich ML, Markowska M. Functional MT1 and MT2 melatonin receptors in mammals. Endocrine 2005 27 : 101 110.
121. Ekmekcioglu C, Haslmayer P, Philipp C et al. 24h variation in the expression of the mt1 melatonin receptor subtype in coronary arteries derived from patients with coronary heart disease. Chronobiol Int 2001 18 : 973 985.
122. Ekmekcioglu C, Thalhammer T, Humpeler S et al. The melatonin receptor subtype MT2 is present in the human cardiovascular system. J Pineal Res 2003 35 : 40 44.
123. Jockers R, Maurice P, Boutin JA et al. Melatonin receptors, heterodimerization, signal transduction and binding sites: what's new?. Br J Pharmacol 2008 154 : 1182 1195.
124. Staiger H, Machicao F, Schäfer SA et al. Polymorphisms within the novel type 2 diabetes risk locus MTNR1B determine beta-cell function. PLoS ONE 2008 3 : e3962.
125. Langenberg C, Pascoe L, Mari A et al. Common genetic variation in the melatonin receptor 1B gene (MTNR1B) is associated with decreased early-phase insulin response. Diabetologia 2009 52 : 1537 1542.
126. Prokopenko Y, Langenberg C, Florez JC et al. Variants in MTNR1B influence casting glucose levels. Nat Genet 2009 41 : 77 81.
127. Lyssenko V, Nagorny CL, Erdos MR et al. Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion. Nat Genet 2009 41 : 82 88.
128. Ha E, Choe BK, Jung KH et al. Positive relationship between melatonin receptor type 1B polymorphism and rheumatoid factor in rheumatoid arthritis patients in the Korean population. J Pineal Res 2005 39 : 201 205.
129. Melatonin receptor 1B (MTNR1B); SNP rs1387153; SNP rs10830963. SciBX 2009, doi:.
130. Hills SA, Balkau B, Coppack SW et al. The EGIR-RISC STUDY (The European group for the study of insulin resistance: relationship between insulin sensitivity and cardiovascular disease risk): I. Methodology and objectives. Diabetologia 2004 47 : 566 570.
131. Sekine A, Saito S, Iida A et al. Identification of single-nucleotide polymorphisms (SNPs) of human N-acetyltransferase genes NAT1, NAT2, AANAT, ARD1 and L1CAM in the Japanese population. J Hum Genet 2001 46 : 314 319.
132. Clarke R, Peden JF, Hopewell JC et al. Genetic variants associated with Lp(a) lipoprotein level and coronary disease. N Engl J Med 2009 361 : 2518 2528.
133. Bhattacharyya S, Luan J, Challis B et al. Sequence variants in the melatonin-related receptor gene (GPR50) associate with circulating triglyceride and HDL levels. J Lipid Res 2006 47 : 761 766.
134. Wakatsuki A, Okatani Y, Ikenoue N et al. Effects of short-term melatonin administration on lipoprotein metabolism in normolipidemic postmenopausal women. Maturitas 2001 38 : 171 177.
135. Reiter RJ, Tan DX, Sainz RN, Mayo JC. Melatonin protects the heart against both ischemia/reperfusion injury and chemotherapeutic drugs. Cardiovasc Drugs Ther 2002 16 : 5 6.
136. Korkmaz A, Reiter RJ. Epigenetic regulation: a new research area for melatonin? J Pineal Res 2008 44 : 41 44.